Public Advisory - TUMS Peppermint Regular Strength tablets: One lot recalled due to contamination
OTTAWA, ON, Nov. 30, 2022 /CNW/ - Summary
Product: TUMS Peppermint Regular Strength tablets, packages of three rolls of 12 tablets, lot HA7H, NPN 01970240
Issue: Health product ? contamination, product safety
What to do: Stop using the recalled product. Speak to a health care professional if you have taken this product and have health concerns.
Affected products
Product
NPN
Lot
Expiry
TUMS Peppermint Regular Strength (500mg) tablets, packages of three rolls of 12 tablets
01970240
HA7H
August 2027
Issue
GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil. The product is sold in a package of three rolls containing 12 tablets each, and was distributed across Canada starting on October 25, 2022.
TUMS is an antacid indicated for adult use to relieve indigestion and heartburn caused by too much acid in the stomach.
If consumed, the fragments should pass through most people's digestive systems with no concern; however, elderly people and people who have narrow areas in their intestines because of disease or surgery may be at risk of injury.
Health Canada is monitoring the company's recall and will update the public if any new health risks are identified.
What you should do
Stop using the recalled product. Contact your health care practitioner if you have used this product and have concerns about your health.
Follow municipal or regional guidelines on how to dispose of chemicals and other hazardous waste; or
Return the product to your local pharmacy for proper disposal
Contact GSK Consumer Healthcare (doing business as Haleon) by calling 1-905-507-7000, or by emailing [email protected], if you have questions about this recall.
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands...
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society (HRS) in the U.S. At Heart Rhythm 2024, the Company will showcase its upper-arm blood...
Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide. Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead...
At the Summit on Clean Cooking in Africa, World Resources Institute (WRI) and the Clean Cooking Alliance (CCA) announced a strategic partnership to further embed clean cooking into a broad range of sustainable development initiatives across the two...
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...